Streptococcus pneumoniae type 4 capsular polysaccharide antigen-specific B cell

The "Streptococcus pneumoniae type 4 capsular polysaccharide antigen-specific B cell" is not a molecule or receptor but instead refers to a population of B lymphocytes that bind and respond specifically to the capsular polysaccharide antigen of Streptococcus pneumoniae serotype 4. These B cells play a crucial role in the adaptive immune response against S. pneumoniae serotype 4 by producing specific antibodies that can facilitate opsonization and bacterial clearance. The immune memory and magnitude of this response can vary with age and immunocompetence and is a focus of vaccine response studies. As this entity is an immune cell population rather than a discrete molecular target, it is not considered a therapeutic target itself, but its presence and function are used as a biomarker for vaccine efficacy and immune competence in response to pneumococcal vaccination. Note on correctness and conventions: This entry is not a canonical molecular target (e.g., enzyme, receptor, transporter) but describes antigen-specific B lymphocyte populations. Accordingly, it is appropriate to set is_target: false and is_incorrect: true, as this does not meet typical definitions for target annotation in drug discovery databases. If you seek information on the actual molecular target (the antigen itself used in vaccines), refer to "Streptococcus pneumoniae type 4 capsular polysaccharide antigen".

Other names

Polysaccharide antigen-specific B cell (type 4, Streptococcus pneumoniae)PPS4-specific B cellPneumococcal capsular polysaccharide type 4-specific B cell

B cells recognizing type 4 capsular polysaccharide undergo activation, antibody class switching, and produce specific IgM/IgG/IgA antibodies upon vaccination or infection